Uterine teratoma and the role of short-tandem repeat genotyping in understanding origins.

IF 1.2 Q3 OBSTETRICS & GYNECOLOGY
Gynecologic Oncology Reports Pub Date : 2024-11-30 eCollection Date: 2024-12-01 DOI:10.1016/j.gore.2024.101652
Abdelrahman AlAshqar, Vijaya Kadam Maruthi, Rita Abi-Raad, Michelle Greenman, Pei Hui, Elena Ratner, Gary Altwerger, Alessandro Santin, Vaagn Andikyan
{"title":"Uterine teratoma and the role of short-tandem repeat genotyping in understanding origins.","authors":"Abdelrahman AlAshqar, Vijaya Kadam Maruthi, Rita Abi-Raad, Michelle Greenman, Pei Hui, Elena Ratner, Gary Altwerger, Alessandro Santin, Vaagn Andikyan","doi":"10.1016/j.gore.2024.101652","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Uterine teratomas are a rare entity with a debated origin. Given its rarity and limitations of diagnostic imaging, diagnosis is typically determined pathologically following surgical resection based on the presence of tissue derived from all germ cell layers. Unlike its ovarian counterpart, the developmental origins are poorly understood; however, recently introduced molecular testing has revolutionized our understanding of these rare tumors.</p><p><strong>Case: </strong>A 44-year-old primiparous woman presented with a four-week history of vaginal bleeding attributed to the presence of a uterine mass. Given the inconclusive results of imaging and endometrial sampling, the patient opted for a total hysterectomy and was diagnosed with a mature cystic uterine teratoma. Short-tandem repeat genotyping performed on the teratoma and fallopian tube tissues confirmed genetic similarity apart from loss of heterozygosity in six of 16 loci.</p><p><strong>Conclusion: </strong>This case demonstrates a mature uterine teratoma potentially arising from host pluripotent stem cells supported by molecular testing. The presence of a diploid karyotype and genetic similarity with the host tissues rule out the possibility of a nonfertilized ovum and residual fetal tissue as the origins, respectively, refuting the blastomere and perhaps the parthenogenetic hypotheses. Future work should utilize advanced molecular testing and investigate the role of pluripotent stem cells in the uterus to enhance our understanding of the origins of these rare tumors.</p>","PeriodicalId":12873,"journal":{"name":"Gynecologic Oncology Reports","volume":"56 ","pages":"101652"},"PeriodicalIF":1.2000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11652878/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic Oncology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.gore.2024.101652","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Uterine teratomas are a rare entity with a debated origin. Given its rarity and limitations of diagnostic imaging, diagnosis is typically determined pathologically following surgical resection based on the presence of tissue derived from all germ cell layers. Unlike its ovarian counterpart, the developmental origins are poorly understood; however, recently introduced molecular testing has revolutionized our understanding of these rare tumors.

Case: A 44-year-old primiparous woman presented with a four-week history of vaginal bleeding attributed to the presence of a uterine mass. Given the inconclusive results of imaging and endometrial sampling, the patient opted for a total hysterectomy and was diagnosed with a mature cystic uterine teratoma. Short-tandem repeat genotyping performed on the teratoma and fallopian tube tissues confirmed genetic similarity apart from loss of heterozygosity in six of 16 loci.

Conclusion: This case demonstrates a mature uterine teratoma potentially arising from host pluripotent stem cells supported by molecular testing. The presence of a diploid karyotype and genetic similarity with the host tissues rule out the possibility of a nonfertilized ovum and residual fetal tissue as the origins, respectively, refuting the blastomere and perhaps the parthenogenetic hypotheses. Future work should utilize advanced molecular testing and investigate the role of pluripotent stem cells in the uterus to enhance our understanding of the origins of these rare tumors.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Gynecologic Oncology Reports
Gynecologic Oncology Reports OBSTETRICS & GYNECOLOGY-
CiteScore
2.00
自引率
0.00%
发文量
183
审稿时长
41 days
期刊介绍: Gynecologic Oncology Reports is an online-only, open access journal devoted to the rapid publication of narrative review articles, survey articles, case reports, case series, letters to the editor regarding previously published manuscripts and other short communications in the field of gynecologic oncology. The journal will consider papers that concern tumors of the female reproductive tract, with originality, quality, and clarity the chief criteria of acceptance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信